{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:18:03Z","timestamp":1790162283348,"version":"4.1.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150621","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T13:43:52Z","timestamp":1457012632000},"page":"e0150621","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":91,"title":["Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"James A. G.","family":"Crispo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison W.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan P.","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlen D.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"McNair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise M.","family":"Bjerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna E.","family":"Kohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Perez-Lloret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Mattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Krewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1517\/14740338.2011.579899","article-title":"Drugs with anticholinergic properties: a current perspective on use and safety","volume":"10","author":"P Gerretsen","year":"2011","journal-title":"Expert opinion on drug safety"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40266-013-0104-x","article-title":"Prevalence and determinants of anticholinergic medication use in elderly dementia patients","volume":"30","author":"SD Sura","year":"2013","journal-title":"Drugs Aging"},{"issue":"Suppl 21","key":"ref3","first-page":"11","article-title":"Anticholinergic effects of medication in elderly patients","volume":"62","author":"LE Tune","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S1041610202008505","article-title":"Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study","volume":"14","author":"D Aizenberg","year":"2002","journal-title":"Int Psychogeriatr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2318-9-30","article-title":"Inappropriate medication use and risk of falls\u2014a prospective study in a large community-dwelling elderly cohort","volume":"9","author":"S Berdot","year":"2009","journal-title":"BMC Geriatr"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jamda.2014.08.002","article-title":"Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home","volume":"15","author":"F Landi","year":"2014","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.1503\/cmaj.141219","article-title":"Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study","volume":"187","author":"WH Lu","year":"2015","journal-title":"CMAJ"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000017167","article-title":"Acetylcholine and delirium","volume":"10","author":"LE Tune","year":"1999","journal-title":"Dementia and geriatric cognitive disorders"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.2009.186239","article-title":"Use of drugs with anticholinergic effect and impact on cognition in Parkinson&apos;s disease: a cohort study","volume":"81","author":"U Ehrt","year":"2010","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.2004.02232.x","article-title":"Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study","volume":"59","author":"N Lechevallier-Michel","year":"2005","journal-title":"British journal of clinical pharmacology"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4140\/TCP.n.2014.158","article-title":"Drug Burden Index score and anticholinergic risk scale as predictors of readmission to the hospital","volume":"29","author":"R Dispennette","year":"2014","journal-title":"The Consultant pharmacist: the journal of the American Society of Consultant Pharmacists"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/1060028014535363","article-title":"Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period","volume":"48","author":"LA Fraser","year":"2014","journal-title":"The Annals of pharmacotherapy"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jgs.13206","article-title":"Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people","volume":"63","author":"MS Salahudeen","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","article-title":"Systematic review of anticholinergic risk scales in older adults","volume":"69","author":"CE Duran","year":"2013","journal-title":"European journal of clinical pharmacology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"MS Salahudeen","year":"2015","journal-title":"BMC Geriatr"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","article-title":"The cholinergic system and Parkinson disease","volume":"221","author":"NI Bohnen","year":"2011","journal-title":"Behav Brain Res"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/mds.23932","article-title":"The interplay of cholinergic function, attention, and falls in Parkinson&apos;s disease","volume":"26","author":"A Yarnall","year":"2011","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"JL Rudolph","year":"2008","journal-title":"Archives of internal medicine"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"H Quan","year":"2005","journal-title":"Med Care"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"C van Walraven","year":"2009","journal-title":"Med Care"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson&apos;s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"SK Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000275491","article-title":"Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries","volume":"34","author":"A Wright Willis","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jgs.13327","article-title":"Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study","volume":"63","author":"KJ Paul","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","article-title":"Anticholinergic activity of 107 medications commonly used by older adults","volume":"56","author":"ML Chew","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00228-015-1919-7","article-title":"Anticholinergic burden in Parkinson&apos;s disease inpatients","volume":"71","author":"U Lertxundi","year":"2015","journal-title":"European journal of clinical pharmacology"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mds.25073","article-title":"Is there an increased risk of hip fracture in Parkinson&apos;s disease? A nationwide inpatient sample","volume":"27","author":"RK Bhattacharya","year":"2012","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.2106\/JBJS.L.01317","article-title":"Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures","volume":"96","author":"M Harris-Hayes","year":"2014","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jnnp-2014-307822","article-title":"Hospitalisation and comorbidities in Parkinson&apos;s disease: a large Australian retrospective study","volume":"86","author":"M Lubomski","year":"2015","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0000000000001715","article-title":"Nursing home and end-of-life care in Parkinson disease","volume":"85","author":"D Safarpour","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archneurol.2011.2370","article-title":"Predictors of survival in patients with Parkinson disease","volume":"69","author":"AW Willis","year":"2012","journal-title":"Archives of neurology"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jhm.1949","article-title":"Delirium in hospitalized patients: implications of current evidence on clinical practice and future avenues for research\u2014a systematic evidence review","volume":"7","author":"BA Khan","year":"2012","journal-title":"J Hosp Med"},{"key":"ref32","article-title":"In geriatric patients, delirium symptoms are related to the anticholinergic burden","author":"M Naja","year":"2015","journal-title":"Geriatr Gerontol Int"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40266-012-0044-x","article-title":"Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study","volume":"30","author":"L Pasina","year":"2013","journal-title":"Drugs Aging"},{"key":"ref34","article-title":"Anticholinergic Exposure During Rehabilitation: Cognitive and Physical Function Outcomes in Patients with Delirium Superimposed on Dementia","author":"A Kolanowski","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"e94944","DOI":"10.1371\/journal.pone.0094944","article-title":"Delirium and high fever are associated with subacute motor deterioration in Parkinson disease: a nested case-control study","volume":"9","author":"A Umemura","year":"2014","journal-title":"PloS one"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mds.26170","article-title":"Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson&apos;s disease","volume":"30","author":"D Weintraub","year":"2015","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3233\/JPD-150664","article-title":"Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson&apos;s Disease?","volume":"5","author":"AJ Yarnall","year":"2015","journal-title":"Journal of Parkinson's disease"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/1999\/316598","article-title":"Induction of a transient dysexecutive syndrome in Parkinson&apos;s disease using a~subclinical dose of scopolamine","volume":"11","author":"MA Bedard","year":"1998","journal-title":"Behavioural neurology"},{"issue":"14","key":"ref39","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","article-title":"Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study","volume":"169","author":"I Carriere","year":"2009","journal-title":"Archives of internal medicine"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"SL Gray","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjmed.2009.02.021","article-title":"Drug burden index score and functional decline in older people","volume":"122","author":"SN Hilmer","year":"2009","journal-title":"Am J Med"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","article-title":"Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine","volume":"151","author":"MH Beers","year":"1991","journal-title":"Archives of internal medicine"},{"key":"ref43","article-title":"Impact of Inappropriate Drug Use on Hospitalizations, Mortality, and Costs in Older Persons and Persons with Dementia: Findings from the SNAC Study","author":"A Skoldunger","year":"2015","journal-title":"Drugs Aging"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jgs.13318","article-title":"Effect of hospitalization on inappropriate prescribing in elderly Medicare beneficiaries","volume":"63","author":"BC Lund","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"15","key":"ref45","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/archinternmed.2010.244","article-title":"Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system","volume":"170","author":"ML Mattison","year":"2010","journal-title":"Archives of internal medicine"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1212\/WNL.0000000000001745","article-title":"Physician response to a medication alert system in inpatients with levodopa-treated diseases","volume":"85","author":"M Morris","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MLR.0000000000000326","article-title":"A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality","volume":"53","author":"NR Thompson","year":"2015","journal-title":"Med Care"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"S Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiology and drug safety"},{"issue":"7","key":"ref49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/gps.2770","article-title":"The prevalence, incidence and risk factors for delirium in Dutch nursing homes and residential care homes","volume":"27","author":"M Boorsma","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/mds.20347","article-title":"Falls and injuries resulting from falls among patients with Parkinson&apos;s disease and other parkinsonian syndromes","volume":"20","author":"CL Wielinski","year":"2005","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1479-8301.2012.00418.x","article-title":"Expert-based drug lists to measure anticholinergic burden: similar names, different results","volume":"13","author":"U Lertxundi","year":"2013","journal-title":"Psychogeriatrics: the official journal of the Japanese Psychogeriatric Society"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jgs.13411","article-title":"Confusion regarding anticholinergic burden measurement","volume":"63","author":"U Lertxundi","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00228-015-1932-x","article-title":"Different methods, different results-how do available methods link a patient&apos;s anticholinergic load with adverse outcomes?","volume":"71","author":"T Mayer","year":"2015","journal-title":"European journal of clinical pharmacology"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/jgs.13647","article-title":"Concordance Between Anticholinergic Burden Scales","volume":"63","author":"JG Naples","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/bcp.12670","article-title":"Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures","volume":"80","author":"LG Pont","year":"2015","journal-title":"British journal of clinical pharmacology"},{"issue":"9","key":"ref56","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00228-013-1535-3","article-title":"Comments on Duran et al.&apos;s systematic review of anticholinergic risk scales (EJCP 2DOI <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1007\/s00228-013-1499-3\" xlink:type=\"simple\">10.1007\/s00228-013-1499-3<\/ext-link>)","volume":"69","author":"U Lertxundi","year":"2013","journal-title":"European journal of clinical pharmacology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.archger.2015.10.002","article-title":"Systematic review on the use of anticholinergic scales in poly pathological patients","volume":"62","author":"AM Villalba-Moreno","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amjopharm.2012.06.003","article-title":"Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation","volume":"10","author":"S Koshoedo","year":"2012","journal-title":"The American journal of geriatric pharmacotherapy"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3810\/hp.2011.02.371","article-title":"Clinical and demographic factors associated with antimuscarinic medication use in older hospitalized patients","volume":"39","author":"E Lowry","year":"2011","journal-title":"Hospital practice (1995)"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2146\/ajhp060624","article-title":"Antidopaminergic therapy for managing comorbidities in patients with Parkinson&apos;s disease","volume":"65","author":"U Lertxundi","year":"2008","journal-title":"American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"e0124356","DOI":"10.1371\/journal.pone.0124356","article-title":"Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson&apos;s disease patients","volume":"10","author":"D Martinez-Ramirez","year":"2015","journal-title":"PloS one"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"e977","DOI":"10.1136\/bmj.e977","article-title":"Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study","volume":"344","author":"KF Huybrechts","year":"2012","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2011.11030347","article-title":"Risk of mortality among individual antipsychotics in patients with dementia","volume":"169","author":"HC Kales","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"DT Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"ref65","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/01.wnl.0000215428.46057.3d","article-title":"Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"66","author":"JM Miyasaki","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 3","key":"ref66","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson&apos;s disease","volume":"26","author":"K Seppi","year":"2011","journal-title":"Movement disorders: official journal of the Movement Disorder Society"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:35:45Z","timestamp":1540334145000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150621"}},"subtitle":[],"editor":[{"given":"Alessandra","family":"Marengoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,3]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150621","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726190387.793516077","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,3]]}}}